Evaluation of Gelatin/Xanthan Gum Based Biomaterial Enhanced with Barbaloin for Wound Healing Application: An In silico and In vitro Study
DOI:
https://doi.org/10.65795/8xppyg43Keywords:
gelatin, xanthan gum, barbaloin, biomaterial, wound healingAbstract
In this study, a gelatin- and xanthan-gum-based biomaterial enhanced with barbaloin was developed and evaluated for its potential application in wound healing. The scaffold was designed to leverage the biocompatibility of gelatin, structural stability provided by xanthan gum, and therapeutic properties of barbaloin. Physicochemical characterization was conducted using FTIR, XRD, and SEM. XRD patterns indicated an amorphous structure, favorable for enhanced swelling and controlled drug release, whereas FTIR confirmed effective molecular interactions among the components. SEM imaging revealed a porous and interconnected architecture that is essential for cell migration and nutrient exchange. Swelling and porosity assessments demonstrated the ability of the scaffold to efficiently absorb wound exudates and maintain a moist environment conducive to tissue regeneration. Biocompatibility, evaluated via the MTT assay, showed high fibroblast viability, confirming the non-toxic nature of the material. Furthermore, molecular docking studies revealed strong binding affinities between barbaloin and wound healing-related proteins, suggesting its role in modulating inflammation and promoting tissue repair. Overall, the Gelatin/Xanthan Gum/Barbaloin scaffold exhibited excellent physicochemical characteristics, cytocompatibility, and therapeutic potential, making it a promising candidate for advanced wound dressing applications.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Raam Kumar, Saranya Srinivasan, Ashwathi Vijayalekha, Ashok Kumar Pandurangan (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright and Licensing
All articles published in Trends in Biomaterials and Artificial Organs are published Open Access. To ensure the widest possible dissemination of research while protecting the integrity of the original work, we utilize the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) 4.0 International License.
User Rights
Under this license, the public is free to share (copy and redistribute the material in any medium or format) under the following terms:
- Attribution: Users must give appropriate credit, provide a link to the license, and indicate if changes were made.
- Non-Commercial: Users may not use the material for commercial purposes. This includes, but is not limited to, the sale of the article or its use in promotional materials for-profit.
- No Derivatives: If a user remixes, transforms, or builds upon the material, they may not distribute the modified material.
Author Rights
Authors retain copyright of their work while granting the journal a non-exclusive license to publish. Because of the NoDerivs (ND) and Non-Commercial (NC) designations:
- Third parties (such as other researchers) must seek permission from the authors/journal to include figures, tables, or portions of the text in new works or commercial publications.
- Authors may deposit the "Version of Record" in institutional repositories immediately upon publication, provided the CC BY-NC-ND 4.0 license is clearly linked.
How to Cite
Accepted 29-04-2026
Published 30-07-2026


